Life Science Growth House is open
Tailored counseling, funding assistance, and innovation hangouts are part of the innovation package offered by the new Life Science Growth House at the University of Oslo.
If you are not happy with the results below please do another search
Tailored counseling, funding assistance, and innovation hangouts are part of the innovation package offered by the new Life Science Growth House at the University of Oslo.
We wish to expand Oslo Cancer Cluster Innovation Park with close to 50 000 square metres the next five to seven years.
Professor Johanna Olweus has been awarded the ERC Consolidator Grant for her cancer research project on immunotherapy.
The Translational Research Unit at the Section for Cellular Therapy based in Norway recently published two groundbreaking studies showcasing the potential of cell-based therapies in combating cancer. The research was developed in the labs of Oslo Cancer Cluster Incubator.
Lytix Biopharma and Curida, both Norwegian-owned, have gained attention and acclaim for their innovative approaches and substantial contributions to the healthcare sector.
A clinical pilot for personalised risk-based breast cancer screening has been conducted as part of the AnteNOR project. Here are some of the results.
In a great achievement, DoMore Diagnostics has been awarded the prestigious EIC Accelerator grant totalling EUR 10 million.
Oslo Cancer Cluster Incubator made the Financial Times Europe’s Leading Start-up Hubs list.
What does it take to make it for new biotech companies?